CytoSorbents Corp. (CTSO)
0.6402
-0.01
(-1.34%)
USD |
NASDAQ |
Feb 20, 16:00
CytoSorbents Research and Development Expense (Quarterly) : 0.918M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Delcath Systems, Inc. | 7.986M |
| Quest Diagnostics, Inc. | -- |
| Danaher Corp. | 438.00M |
| Cardiac Biotech Solutions, Inc. | 0.028M |
| Odyssey Health, Inc. | 0.00 |